Ketamine Infusions in the Home May Facilitate Safe Treatment Access During the Pandemic
Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, explains how ketamine infusions work when administered in patients’ homes and what safety precautions would be taken by providers in this setting.
Pharmacy Times interviewed Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, on the implications of a survey that showed 65% of affected Americans want access to psychedelics for the treatment of mental health conditions.
Specifically, data have shown that patients with treatment-resistant anxiety, depression, and post-traumatic stress disorder are among those who would benefit from an expanded therapeutic regimen that includes psychedelic medicines, which have been found to be both effective and safe in the treatment of these conditions.
During the discussion, Marques explained how ketamine infusions work, what at-home ketamine infusions might look like, and what safety precautions would be taken when administering ketamine infusions in the home.
